Monthly Archives: June 2009

Change Begets Opportunity

Posted on June 22, 2009 by Mark Senak

At the time that President Obama won the election in November 2008, it was still too early to foresee the vast amounts of change that the nation faced.   His campaign was built on change, but once the economy began to … Continue reading →

Posted in FDA Policy | Comments Off on Change Begets Opportunity

Hamburg – Good Medicine

Posted on June 17, 2009 by Mark Senak

Today the Washington Post has an article – "FDA Commissioner Faces Formidable To Do List" that outlines the many challenges that Dr. Margaret Hamburg and Dr. Joshua Sharfstein face as they get settled into their new jobs.  This includes the … Continue reading →

Posted in FDA Image, FDA Policy | 2 Comments

Fact or Fiction – FDA Has a Policy on Social Media?

Posted on June 16, 2009 by Mark Senak

This, apparently, is a stampede in progress…. Today the Post ran a story in its Health Section that had the headline "Drug Firms Jockey for Space Online" and when the story print continuity breaks and carries on to a subsequent … Continue reading →

Posted in New and Social Media | 10 Comments

Eschewing Tobacco

Posted on June 15, 2009 by Mark Senak

Late last week the Senate finally voted along with the House to give authority to the FDA to regulate tobacco – a move specifically required when the silly Supreme Court said that the FDA did not have such authority.  That … Continue reading →

Posted in FDA Policy | 1 Comment

What Do Facebook Changes Mean for Pharma?

Posted on June 11, 2009 by Mark Senak

Well, in most circumstances, not much.  If you consider the fact that most pharmaceutical companies aren't engaged with Facebook on a widespread level at the current time, the fact that Facebook is making an interesting change to its pages doesn't … Continue reading →

Posted in New and Social Media | 3 Comments